GlucoTrack Inc(GCTK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -180.43 | Insider Own | 19.49% | Shs Outstand | 0.4M | Perf Week | -41.34% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -71.69% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 4.42% | Short Float | - | Perf Quarter | -85.81% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | 16% | Short Ratio | 0.06 | Perf Half Y | -94.2% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -272.48% | Short Interest | 0.12M | Perf YTD | -98.88% |
| Book/sh | -4.17 | P/C | 1.38 | EPS past 3/5Y | 73.72% 50.71% | ROE | -620.63% | 52W High | -99.42% ($112.50) | Perf Year | -99.37% |
| Cash/sh | 0.47 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | -4.53% ($0.68) | Perf 3Y | -100% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 99.51% | Gross Margin | - | Volatility(W/M) | 17.15% 15.58% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.26 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 0.46 | EPS Q/Q | 92.08% | Profit Margin | - | RSI (14) | 24.57 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.46 | Sales Q/Q | - | SMA20 | -49.55% ($1.29) | Beta | 0.81 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -77.28% ($2.86) | Rel Volume | 0.03 | Prev Close | $0.68 |
| Employees | 15 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -95.33% ($13.92) | Avg Volume(3M) | 1.90M | Price | $0.65 |
| IPO | 2013/4/25 | Option/Short | No/Yes | Trades | 395 | Volume | 50,929 | Change | -4.91% |
🩺 Medical technology company. Non-invasive blood glucose monitoring. Developing an implantable continuous glucose monitor (CGM). Clinical trials underway. Pursuing FDA approval.
Over the past 1 year, on the lower side
99% below its 1-year high.
Traded less than usual. That is 3% of its average volume.
GCTK has weak earnings and a weak balance sheet
Review management risk carefully before investing
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -100.0%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 4.4%.
Tap to view numbers
It ranks #141 of 142 in the industry
Based on market cap of $2M.
IVF#137 INVO Fertility Inc $3M PER - 
NXL#138 Nexalin Technology Inc $2M PER - 
XAIR#139 Beyond Air Inc $2M PER - 
NUWE#140 Nuwellis Inc $2M PER - GCTK#141 GlucoTrack Inc $2M PER - 
FAQ
What kind of company is GCTK?
GCTK belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of GCTK?
The market cap of GCTK is approximately $2M, ranking 5,839 within its sector.
What is the 52-week high and low for GCTK?
GCTK has recorded a 52-week high of $112.50 and a low of $0.68.
